60 likes | 72 Views
Across the world, the lifestyle is becoming increasingly sedentary and fast paced. While sitting on a chair in offices all day leads to physical inactivity, the fast pace of life results in emotional stress. With lack of time, peopleu2019s dietary pattern gets affected, which leads to improper nutrition. <br>All these factors, combined with tobacco and alcohol abuse, result in chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, and several cardiovascular diseases (CVD), the prevalence of all of which is rising. As per the World Health Organization, the number of
E N D
Sharp Surge Expected in Asia-Pacific Transdermal Drug Delivery Systems © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved Market in Future 1
The global transdermal drug delivery systems market is set for lucrative growth in the coming years. The market is being driven by the surging population of geriatric people, the rising incidence of chronic diseases such as diabetes, angina, and hypertension, the increasing adoption of advanced drug delivery system technologies, the soaring concerns being raised over painless drug delivery, the increasing number of patients diagnosed with neurovascular diseases, and the various benefits provided by transdermal drug delivery systems. Receive Sample Pages of this Report: https://www.psmarketresearch.com/market-analysis/transdermal- drug-delivery-systems-market/report-sample The increasing occurrence rate of diabetes is one of the major factors fueling the advancement of the market across the globe. As per the International Diabetes Federation (IDF), nearly 425 million people all over the world in the age bracket 20–79 years were diagnosed with diabetes in 2017 and this number is predicted to rise to 629 million by 2045. Apart from the growing incidence of chronic diseases, the surging geriatric population is also fueling the market expansion. As per the global aging population report published by the United Nations Department of Economic and Social Welfares (UNDESA), the total number of people above 60 years of age across the world is predicted to rise from 962 million in 2017 to 2.1 billion by 2050. Moreover, according to the observations of the Centers of Disease control and Prevention (CDC), in America, one out of every three adults suffer from high blood pressure. Furthermore, the organization found that only 54% of the people suffering from high blood pressure in the U.S. have their condition under control. Depending on the type of delivery system, the transdermal drug delivery systems market is divided into passive and active delivery systems. Between these, the passive delivery system category will hold higher market share in the future. This will be because of the growing incidence of chronic diseases such as hypertension and the mushrooming usage of these devices. When application is taken into consideration, the market is categorized into hormone replacement therapy, analgesics, cardiovascular diseases, hypertension, smoking cessation, and motion sickness. Out of these, the analgesics category recorded the highest growth in the market in the past years and it will demonstrate rapid expansion in the forthcoming years as well, according to the estimates of the market research company, P&S Intelligence. Furthermore, the requirement for these devices in cardiovascular disorder applications is growing rapidly across the world. Geographically, the transdermal drug delivery systems market is predicted 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
to exhibit the fastest growth in the Asia-Pacific (APAC) region in the future years. This will be a result of the huge investments being made by the governments of several regional countries on healthcare and the increasing implementation of supportive reimbursement policies in the region. Additionally, the soaring healthcare expenditure and the rapid improvements being made in the healthcare infrastructure are massively propelling the market expansion in the region. Hence, it can be said with full confidence that the market will register huge growth across the world in the coming years, primarily because of the growing incidence of chronic diseases such as diabetes, the rapidly increasing geriatric population, and the soaring healthcare expenditure in several countries. The research offers market size of the global dermacosmetics market for the period 2015– 2030. Market Segmentation by Product Skincare • oCream oSerum oLotion oCleanser oGel oToner oOthers Haircare • oShampoo oConditioner oOthers Market Segmentation by Treatment Skin • oAnti-aging oSkin whitening oAcne treatment oOthers Hair • oAnti-dandruff oAnti-hair fall oHair repair oOthers 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
Market Segmentation by Distribution Channel Pharmacies & Retail Stores Online Channels Market Segmentation by End User Clinics, Medical Spas, & Salons At-Home Hospitals Market Segmentation by Region Europe Dermacosmetics Market • • • • • • oBy product oBy treatment oBy distribution channel oBy end user oBy country – France, Italy, Germany, U.K., Spain, Russia, Switzerland, Sweden, Norway, Denmark, Poland, and Rest of Europe North America Dermacosmetics Market • oBy product oBy treatment oBy distribution channel oBy end user oBy country – U.S. and Canada Asia-Pacific (APAC) Dermacosmetics Market • oBy product oBy treatment oBy distribution channel oBy end user oBy country – China, India, Japan, South Korea, Indonesia, Australia, Singapore, Thailand, Malaysia, Sri Lanka, and Rest of APAC Latin America (LATAM) Dermacosmetics Market • oBy product oBy treatment oBy distribution channel oBy end user oBy country – Brazil, Mexico, Argentina, Chile, Colombia, Ecuador, and Rest of LATAM Middle East & Africa (MEA) Dermacosmetics Market • 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
oBy product oBy treatment oBy distribution channel oBy end user oBy country – Saudi Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, and Rest of MEA 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved